Standard BioTools Gross Margin 2010-2025 | LAB

Current and historical gross margin for Standard BioTools (LAB) over the last 10 years. The current gross profit margin for Standard BioTools as of March 31, 2025 is %.
Standard BioTools Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.17B $0.08B 47.06%
2024-12-31 $0.18B $0.08B 48.00%
2024-09-30 $0.16B $0.08B 48.08%
2024-06-30 $0.14B $0.06B 46.32%
2024-03-31 $0.13B $0.06B 48.82%
2023-12-31 $0.11B $0.05B 47.17%
2023-09-30 $0.11B $0.05B 45.71%
2023-06-30 $0.11B $0.05B 43.40%
2023-03-31 $0.10B $0.04B 37.11%
2022-12-31 $0.10B $0.04B 36.36%
2022-09-30 $0.11B $0.05B 40.91%
2022-06-30 $0.11B $0.05B 44.25%
2022-03-31 $0.13B $0.06B 49.60%
2021-12-31 $0.13B $0.07B 52.67%
2021-09-30 $0.14B $0.08B 54.35%
2021-06-30 $0.15B $0.09B 57.72%
2021-03-31 $0.14B $0.09B 59.03%
2020-12-31 $0.14B $0.08B 58.99%
2020-09-30 $0.13B $0.07B 58.73%
2020-06-30 $0.11B $0.06B 56.25%
2020-03-31 $0.11B $0.06B 55.26%
2019-12-31 $0.12B $0.06B 55.17%
2019-09-30 $0.12B $0.07B 56.03%
2019-06-30 $0.12B $0.07B 56.30%
2019-03-31 $0.12B $0.07B 56.41%
2018-12-31 $0.11B $0.06B 55.36%
2018-09-30 $0.11B $0.06B 52.78%
2018-06-30 $0.10B $0.05B 50.96%
2018-03-31 $0.10B $0.05B 50.00%
2017-12-31 $0.10B $0.05B 50.49%
2017-09-30 $0.10B $0.05B 52.00%
2017-06-30 $0.10B $0.05B 53.61%
2017-03-31 $0.10B $0.06B 55.45%
2016-12-31 $0.10B $0.06B 56.73%
2016-09-30 $0.11B $0.06B 57.27%
2016-06-30 $0.12B $0.07B 58.12%
2016-03-31 $0.12B $0.07B 58.47%
2015-12-31 $0.12B $0.07B 58.62%
2015-09-30 $0.12B $0.07B 60.17%
2015-06-30 $0.12B $0.07B 60.50%
2015-03-31 $0.12B $0.07B 61.86%
2014-12-31 $0.12B $0.07B 63.25%
2014-09-30 $0.11B $0.07B 64.76%
2014-06-30 $0.09B $0.06B 67.74%
2014-03-31 $0.08B $0.06B 70.73%
2013-12-31 $0.07B $0.05B 71.83%
2013-09-30 $0.07B $0.05B 71.21%
2013-06-30 $0.06B $0.04B 70.49%
2013-03-31 $0.06B $0.04B 68.42%
2012-12-31 $0.05B $0.04B 67.92%
2012-09-30 $0.05B $0.03B 68.00%
2012-06-30 $0.05B $0.03B 66.67%
2012-03-31 $0.05B $0.03B 67.39%
2011-12-31 $0.04B $0.03B 68.18%
2011-09-30 $0.04B $0.03B 68.29%
2011-06-30 $0.04B $0.03B 71.05%
2011-03-31 $0.04B $0.02B 68.57%
2010-12-31 $0.03B $0.02B 66.67%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.467B $0.174B
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.804B 58.27
Tempus AI (TEM) United States $11.365B 0.00
Doximity (DOCS) United States $10.890B 50.42
Hims & Hers Health (HIMS) United States $9.396B 97.63
IRhythm Technologies (IRTC) United States $4.819B 0.00
Inspire Medical Systems (INSP) United States $3.834B 59.90
Hinge Health (HNGE) United States $3.409B 0.00
Privia Health (PRVA) United States $2.635B 180.08
Enovis (ENOV) United States $1.711B 9.54
Phreesia (PHR) United States $1.608B 0.00
Schrodinger (SDGR) United States $1.493B 0.00
Clover Health Investments (CLOV) United States $1.440B 0.00
Azenta (AZTA) United States $1.334B 61.98
Omnicell (OMCL) United States $1.329B 23.45
10x Genomics (TXG) United States $1.329B 0.00
Evolent Health (EVH) United States $1.233B 105.00
Claritev (CTEV) United States $0.682B 0.00
Fulgent Genetics (FLGT) United States $0.588B 0.00
Butterfly Network (BFLY) United States $0.507B 0.00
Veradigm (MDRX) United States $0.486B 0.00
Talkspace (TALK) United States $0.462B 138.00
TruBridge (TBRG) United States $0.337B 748.33
Outset Medical (OM) United States $0.308B 0.00
Nyxoah SA (NYXH) Belgium $0.267B 0.00
Health Catalyst (HCAT) United States $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.203B 0.00
KORU Medical Systems (KRMD) United States $0.158B 0.00
EUDA Health Holdings (EUDA) Singapore $0.133B 0.00
CareCloud (CCLD) United States $0.105B 4.02
American Well (AMWL) United States $0.105B 0.00
Pulmonx (LUNG) United States $0.103B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
111 (YI) China $0.066B 0.00
HeartBeam (BEAT) United States $0.050B 0.00
P3 Health Partners (PIII) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.044B 0.00
Zepp Health (ZEPP) Netherlands $0.035B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Precipio (PRPO) United States $0.016B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00